Latest Laboratory techniques Stories

ZURICH, Jan. 13, 2012 /PRNewswire/ -- IBM (NYSE: IBM) scientists have developed a flexible, non-contact microfluidic probe made from silicon that can aid researchers and pathologists to investigate critical tissue samples accurately for drug discovery and disease diagnostics. Flickr Photos: http://www.flickr.com/photos/ibm_research_zurich/sets/72157628678347543 Tissue staining is widely used in pathology to detect disease markers in a patient's sample. More specifically,...

HAYWARD, Calif., Jan. 5, 2012 /PRNewswire/ -- Molecular diagnostics company GenturaDx announced today that the company will present at the Biotech Showcase Conference on Monday, January 9 at 9:15 a.m. Pacific Time at the Parc 55 Wyndham Hotel in San Francisco. Mark Bagnall, president and CEO of GenturaDx, will provide an update on the company and the IDbox(TM) system. The company is currently in beta studies with clinical trials to start mid-2012. About GenturaDxGenturaDx is a...

FREMONT, Calif., Jan. 5, 2012 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that the company plans to deliver its corporate presentation at the 5(th) Annual OneMedForum San Francisco 2012, at the Sir Francis Drake Hotel, San Francisco, Calif., January 9-12, 2012. The company is scheduled to present on Tuesday, January 10, 2012 beginning at 10:00 a.m. Pacific Time. The presentation will be available live and for...

The handheld Dino-Lite AM4113T-GFBW is a critical benefit to geneticists and bio-engineering researchers. Roanoke, Virginia (PRWEB) January 02, 2012 Microscope.com, in partnership with BigC.com, is pleased to introduce the Dino-Lite AM4113T-GFBW to the world of microscopy. With blue LEDs for excitation and a 510nm emission filter, this new microscope can observe green fluorescence protein (GFP) activity in live cells, a critical benefit to the geneticist or bio-engineering researcher....

MANSFIELD, Mass., Jan. 3, 2012 /PRNewswire/ -- PrimeraDx today announced that David Jackson has been appointed as the Vice President of Business Development. "David has extensive capabilities in companion diagnostic partnerships, and his experience with DxS and Qiagen is well aligned with the company's strategy to be the platform of choice in the burgeoning companion diagnostics market," said Matt McManus, President and CEO, PrimeraDx. "PrimeraDx has the most innovative qPCR based...

TSXV: CNC OTCBB: CNYC VANCOUVER, Dec. 20, 2011 /PRNewswire/ - Canyon Copper Corp. ("Canyon Copper") (TSX-V: CNC) (OTCBB: CNYC) is pleased to advise that the new assay results for the 33 drill hole program carried out on Longshot Ridge in 2006 have been received and will be applied in a recalculation of the 2010 resource estimate, which mineralization was modeled using only those holes drilled in the years previous to the 2006 program. The assays are from drill holes that were...

TUCSON, Ariz., Dec. 13, 2011 /PRNewswire/ -- Ventana Medical Systems Inc. (Ventana), a member of the Roche Group, and Advanced Cell Diagnostics Inc. (ACD), announced today they have entered a worldwide co-promotion agreement for the first commercially available, fully automated RNA in situ hybridization (ISH) assay system capable of robust detection and visualization of virtually any expressed gene in routine clinical specimens at single-molecule sensitivity. (Photo:...

FREMONT, Calif., Dec. 8, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that the company plans to deliver its corporate presentation at the Oppenheimer 22nd Annual Healthcare Conference at the Waldorf-Astoria, New York, NY, December 13-14, 2011. The Company is scheduled to present on Tuesday, December 13, 2011 from 3:35-3:50 p.m. Eastern Time. The presentation will be webcast live and will be available for...

MANSFIELD, Mass., Dec. 6, 2011 /PRNewswire/ -- PrimeraDx today announced that Leroy Hood, MD, PhD, a world recognized leader in the molecular device industry, has been appointed to its Scientific Advisory Board. "High multiplex qPCR diagnostics is a key step in bringing personalized medicine to the clinic," commented Dr. Hood. "I am delighted to help PrimeraDx take the step from an innovative next generation qPCR platform to a robust molecular diagnostics solution." "Lee...

MANSFIELD, Mass., Dec. 1, 2011 /PRNewswire/ -- PrimeraDx today announced that David Heffelfinger has been appointed as Vice President of Engineering and Systems Development. "It is an exciting time to join PrimeraDx. The ICEPlex® System offers a glimpse into the future of molecular diagnostics, providing capabilities that are essential and timely," Commented Mr. Heffelfinger. "David brings to PrimeraDx extensive experience in the medical device industry and is a great...